327 related articles for article (PubMed ID: 28386633)
1. RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.
Singhal SS; Nagaprashantha L; Singhal P; Singhal S; Singhal J; Awasthi S; Horne D
Pharm Res; 2017 Aug; 34(8):1673-1682. PubMed ID: 28386633
[TBL] [Abstract][Full Text] [Related]
2. Targeting p53-null neuroblastomas through RLIP76.
Singhal J; Yadav S; Nagaprashantha LD; Vatsyayan R; Singhal SS; Awasthi S
Cancer Prev Res (Phila); 2011 Jun; 4(6):879-89. PubMed ID: 21411502
[TBL] [Abstract][Full Text] [Related]
3. Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis.
Singhal SS; Wickramarachchi D; Yadav S; Singhal J; Leake K; Vatsyayan R; Chaudhary P; Lelsani P; Suzuki S; Yang S; Awasthi YC; Awasthi S
Mol Cancer Ther; 2011 Jan; 10(1):16-28. PubMed ID: 21220488
[TBL] [Abstract][Full Text] [Related]
4. The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance.
Awasthi YC; Sharma R; Yadav S; Dwivedi S; Sharma A; Awasthi S
Curr Drug Metab; 2007 May; 8(4):315-23. PubMed ID: 17504221
[TBL] [Abstract][Full Text] [Related]
5. RLIP76 Targeted Therapy for Kidney Cancer.
Singhal SS; Singhal J; Figarola J; Horne D; Awasthi S
Pharm Res; 2015 Oct; 32(10):3123-36. PubMed ID: 26021465
[TBL] [Abstract][Full Text] [Related]
6. Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters.
Yadav S; Zajac E; Singhal SS; Awasthi S
Cancer Metastasis Rev; 2007 Mar; 26(1):59-69. PubMed ID: 17260165
[TBL] [Abstract][Full Text] [Related]
7. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.
Singhal SS; Sehrawat A; Sahu M; Singhal P; Vatsyayan R; Rao Lelsani PC; Yadav S; Awasthi S
Int J Cancer; 2010 Mar; 126(6):1327-38. PubMed ID: 19626587
[TBL] [Abstract][Full Text] [Related]
8. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways.
Cheng J; Fan YH; Xu X; Zhang H; Dou J; Tang Y; Zhong X; Rojas Y; Yu Y; Zhao Y; Vasudevan SA; Zhang H; Nuchtern JG; Kim ES; Chen X; Lu F; Yang J
Cell Death Dis; 2014 Feb; 5(2):e1079. PubMed ID: 24556694
[TBL] [Abstract][Full Text] [Related]
9. Regression of melanoma in a murine model by RLIP76 depletion.
Singhal SS; Awasthi YC; Awasthi S
Cancer Res; 2006 Feb; 66(4):2354-60. PubMed ID: 16489041
[TBL] [Abstract][Full Text] [Related]
10. Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.
Lu J; Guan S; Zhao Y; Yu Y; Wang Y; Shi Y; Mao X; Yang KL; Sun W; Xu X; Yi JS; Yang T; Yang J; Nuchtern JG
Oncotarget; 2016 Dec; 7(50):82757-82769. PubMed ID: 27764791
[TBL] [Abstract][Full Text] [Related]
11. Activating p53 function by targeting RLIP.
Singhal SS; Horne D; Singhal J; Awasthi S; Salgia R
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188512. PubMed ID: 33460725
[TBL] [Abstract][Full Text] [Related]
12. RLIP76: A novel glutathione-conjugate and multi-drug transporter.
Singhal SS; Yadav S; Roth C; Singhal J
Biochem Pharmacol; 2009 Mar; 77(5):761-9. PubMed ID: 18983828
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
[TBL] [Abstract][Full Text] [Related]
14. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis.
Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX
Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796
[TBL] [Abstract][Full Text] [Related]
15. Regression of prostate cancer xenografts by RLIP76 depletion.
Singhal SS; Roth C; Leake K; Singhal J; Yadav S; Awasthi S
Biochem Pharmacol; 2009 Mar; 77(6):1074-83. PubMed ID: 19073149
[TBL] [Abstract][Full Text] [Related]
16. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
Singhal SS; Yadav S; Singhal J; Zajac E; Awasthi YC; Awasthi S
Biochem Pharmacol; 2005 Aug; 70(3):481-8. PubMed ID: 15950949
[TBL] [Abstract][Full Text] [Related]
17. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
18. POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis.
Yadav S; Zajac E; Singhal SS; Singhal J; Drake K; Awasthi YC; Awasthi S
Biochem Biophys Res Commun; 2005 Mar; 328(4):1003-9. PubMed ID: 15707977
[TBL] [Abstract][Full Text] [Related]
19. Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity.
Awasthi S; Singhal SS; Singhal J; Yang Y; Zimniak P; Awasthi YC
Int J Oncol; 2003 Apr; 22(4):721-32. PubMed ID: 12632061
[TBL] [Abstract][Full Text] [Related]
20. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes.
Sharma R; Singhal SS; Cheng J; Yang Y; Sharma A; Zimniak P; Awasthi S; Awasthi YC
Arch Biochem Biophys; 2001 Jul; 391(2):171-9. PubMed ID: 11437348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
